Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
AstraZeneca
Compass Therapeutics
Exelixis
Mayo Clinic
Mayo Clinic
Ohio State University
Hoffmann-La Roche
Xencor, Inc.
AstraZeneca
Neonc Technologies, Inc.
ViroMissile, Inc.
Arcus Biosciences, Inc.
AstraZeneca
Pfizer
Duke University